6-Dehydrogingerdione enhances TRAIL-induced apoptosis in Hep G2 cells via ROS-mediated DR5 upregulation and p53 activation. This compound is a useful research tool for studying p53-dependent apoptotic pathways and TRAIL sensitization mechanisms in cancer cell models, including hepatoblastoma, in vitro.